VCTC
VCTC is a specialist clinical trial center dedicated to making clinical trials more accessible through virtual and decentralized trials. The company's innovative approach aims to accelerate and improve research outcomes, enabling better clinical decision-making and facilitating the faster introduction of new medical treatments. Participants are at the center of VCTC's mission, with a focus on providing an exceptional, safe, and inclusive experience. The company's team of medical, scientific, and clinical specialists ensures participants and clients have access to necessary expertise, resulting in enhanced research evidence and high participant retention rates.
The company provides comprehensive support for all components of clinical research, from leading trials end-to-end to developing accessible trial guidance and materials. VCTC is committed to pushing boundaries and continually improving the quality of clinical research, aiming to lead a lasting, meaningful transformation in how clinical research is conducted worldwide.
Founded in 2022 and headquartered in the United Kingdom, VCTC operates within the Biotechnology and Health Care industries. As of now, there is no information available regarding the last investment or investors.
There is no investment information
No recent news or press coverage available for VCTC.